Randomized controlled trial on the usefulness of hochuekkito for fatigue and anorexia during cancer chemotherapy

Randomized controlled trial on the usefulness of hochuekkito for fatigue and anorexia during cancer chemotherapy - Hochuekkito for the side effects of cancer chemotharapy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000985

Enrollment

100

Registered

2008-01-20

Start date

2008-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

oral administration of hochuekkito no treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosis: histologically-proven cancer patients of any organs Disease duration: no limitation Severity: no limitation of cancer stage, performance status (PS): 0-2, capable of outpatient setting

Exclusion criteria

Exclusion criteria: Present illness: no limitation Past history: no limitation Combined treatment: no limitation Combined drugs: Kampo drugs other than hochuekkito, and vitamins etc can be continued. New addition of these drugs is prohibited.

Design outcomes

Primary

Measure	Time frame
Subjective symptoms such as fatigue and anorexia, and quality of life	—

Secondary

Measure	Time frame
Rate of treatment accomplishment, dose intensity, and median survival time	—

Countries

Japan

Contacts

Public ContactYoshiharu MOTOO

Kanazawa Medical University Multidisciplinary Cancer Center

cancer@kanazawa-med.ac.jp076-286-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026